Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

High-Volume Injection with and without Corticosteroid in Chronic Midportion Achilles Tendinopathy

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Prevalence and severity of groin problems in Spanish football: A prospective study beyond the time-loss approach

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Cardiovascular and metabolic health effects of team handball training in overweight women: Impact of prior experience

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Physical activity during pregnancy and intelligence in sons; A cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Influence of between-limb asymmetry in muscle mass, strength, and power on functional capacity in healthy older adults

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Investigating circadian clock gene expression in human tendon biopsies from acute exercise and immobilization studies

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Tendinopati hos idrætsfolk

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Validity and reliability of an ultrasound measurement of the free length of the Achilles tendon

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Kronisk achillessene tendinopati

    Publikation: Bidrag til tidsskriftTidsskriftartikelFormidling

Vis graf over relationer

BACKGROUND: High volume injection (HVI) shows promising results in the treatment of chronic midportion Achilles tendinopathy (AT). HVI consists of a large volume of saline with a small amount of corticosteroid and local anesthetic.

OBJECTIVE: To determine the effect of corticosteroid in HVI in AT.

METHODS: A total of 28 men (18-59 years) with chronic (>3 months) AT were included in a double-blinded RCT and followed for 24 weeks. All performed eccentric training and randomized to either (a) HVI injection with corticosteroid or (b) HVI injection without corticosteroid. Outcomes included self-reported function (VISA-A score) and pain (VAS score) and ultrasound imaging (tendon thickness, Doppler flow).

RESULTS: VISA-A and VAS score improved in both groups at all time-points (P < 0.05). VISA-A improvement was significantly greater in HVI with corticosteroid (mean ± SEM; 6-weeks = 31 ± 3 points; 12-weeks = 32 ± 5 points) vs HVI without corticosteroid (6 weeks = 14 ± 3; 12-weeks = 17 ± 3) at 6 and 12 weeks (P < 0.05), but not at 24 weeks. Decrease in VAS scores was significantly greater in HVI with corticosteroid (6 weeks = 55 ± 3 mm; 12 weeks = 53 ± 5 mm) vs HVI without corticosteroid (6 weeks = 16 ± 3 mm; 12 weeks = 25 ± 5 mm) at 6 and 12 weeks (P < 0.05) but not at 24 weeks. Tendon thickness decreased significantly in both groups at all time-points (P < 0.05), but more in the HVI with corticosteroid vs HVI without corticosteroid at 6 and 12 weeks (P < 0.05) but not at 24 weeks.

CONCLUSION: High volume injection with or without corticosteroid in combination with eccentric training seems effective in AT. HVI with corticosteroid showed a better short-term improvement than HVI without corticosteroid indicating a short-term effect of corticosteroid in HVI treatment of AT.

OriginalsprogEngelsk
TidsskriftScandinavian journal of medicine & science in sports
Vol/bind29
Udgave nummer8
Sider (fra-til)1223-1231
Antal sider9
ISSN0905-7188
DOI
StatusUdgivet - aug. 2019

ID: 57091163